These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10760436)

  • 1. Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition.
    Amorino GP; Freeman ML; Carbone DP; Lebwohl DE; Choy H
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):399-405. PubMed ID: 10760436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
    Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
    Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of acquired resistance to the orally active platinum-based anticancer drug bis-acetato-ammine-dichloro-cyclohexylamine platinum (i.v.) (JM216) in two human ovarian carcinoma cell lines.
    Mellish KJ; Kelland LR
    Cancer Res; 1994 Dec; 54(23):6194-200. PubMed ID: 7954466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.
    Reardon JT; Vaisman A; Chaney SG; Sancar A
    Cancer Res; 1999 Aug; 59(16):3968-71. PubMed ID: 10463593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
    Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of platinum drugs with clinically relevant x-ray doses in mammalian cells: a comparison of cisplatin, carboplatin, iproplatin, and tetraplatin.
    Skov K; MacPhail S
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):221-5. PubMed ID: 1991682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of the orally active cisplatin analog, JM216, and radiation in antitumor therapy.
    Amorino GP; Mohr PJ; Hercules SK; Pyo H; Choy H
    Cancer Chemother Pharmacol; 2000; 46(5):423-6. PubMed ID: 11127948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
    Mellish KJ; Kelland LR; Harrap KR
    Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral platinum analogue JM216, a radiosensitizer in oxic murine cells.
    van de Vaart PJ; Klaren HM; Hofland I; Begg AC
    Int J Radiat Biol; 1997 Dec; 72(6):675-83. PubMed ID: 9416790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of the orally active camptothecin analog, RFS-2000 (9-nitro-20(S)-camptothecin) as a radiation enhancer.
    Amorino GP; Hercules SK; Mohr PJ; Pyo H; Choy H
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):503-9. PubMed ID: 10802379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of platinum-DNA adduct repair.
    Chaney SG; Vaisman A
    J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of radiation-induced cell kill by platinum complexes (carboplatin and iproplatin) in V79 cells.
    O'Hara JA; Douple EB; Richmond RC
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1419-22. PubMed ID: 3531116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
    Orr RM; O'Neill CF; Nicolson MC; Barnard CF; Murrer BA; Giandomenico CM; Vollano JF; Harrap KR
    Br J Cancer; 1994 Sep; 70(3):415-20. PubMed ID: 8080724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
    Fokkema E; Groen HJ; Helder MN; de Vries EG; Meijer C
    Biochem Pharmacol; 2002 Jun; 63(11):1989-96. PubMed ID: 12093475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance.
    Li L; Keating MJ; Plunkett W; Yang LY
    Mol Pharmacol; 1997 Nov; 52(5):798-806. PubMed ID: 9351970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY; Rogers PM; Kelland LR
    Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The radiomimetic properties of a platinum drug.
    Barot HA; Laverick M; Nias AH
    Br J Radiol; 1985 Jan; 58(685):51-62. PubMed ID: 3840711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of DNA mismatch repair in platinum drug resistance.
    Fink D; Nebel S; Aebi S; Zheng H; Cenni B; Nehmé A; Christen RD; Howell SB
    Cancer Res; 1996 Nov; 56(21):4881-6. PubMed ID: 8895738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of radiation effects by combined docetaxel and carboplatin treatment in vitro.
    Amorino GP; Hamilton VM; Choy H
    Radiat Oncol Investig; 1999; 7(6):343-52. PubMed ID: 10644057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.